hepatitis

3rd European Chemsex Forum

Paris, France,

The 3rd European Chemsex Forum will be a 2½ day, multi-disciplinary event, in Paris, 14-16 November 2019.

Activities include an evening opening with keynote speeches on Thursday, the Data and Evidence Day on Friday, and the Community Mobilisation Day on Saturday.

8th International Conference on Hepatitis Care in Substance Users

Montréal,

The 8th INHSU conference covers the latest advances on hepatitis C epidemiology, management and treatment of viral hepatitis among people who use drugs, with a specific focus on hepatitis C.

Through the dissemination of scientific knowledge, the conference aims to contribute to the World Health Organization’s goal of eliminating hepatitis C by 2030.

HepHIV2019 Conference

Bucharest, Romania,

The HepHIV2019 conference, which is organised jointly with the 3-year EU funded joint action INTEGRATE, will take place 28-30 January 2019 in Bucharest, Romania.

State HCV Incidence and Policies Related to HCV Preventive and Treatment Services for Persons Who Inject Drugs — United States, 2015–2016

Citation
Campbell CA, Canary L, Smith N, Teshale E, Ryerson AB, Ward JW. State HCV Incidence and Policies Related to HCV Preventive and Treatment Services for Persons Who Inject Drugs — United States, 2015–2016. MMWR Morb Mortal Wkly Rep 2017;66:465–469. DOI: http://dx.doi.org/10.15585/mmwr.mm6618a2
Publication Date

Summary

What is already known about this topic?

The United States has experienced a sharp increase in hepatitis C virus (HCV) incidence that can be attributed to injection drug use. Some states have used public health laws and treatment policies to reduce the risk for transmission of HCV infections among persons who inject drugs.

What is added by this report?